UKMi Q&A xx - SPS

Candesartan, losartan and valsartan are the ARB’s so far to have been granted marketing authorisation for heart failure. (4) Losartan is not licensed to be used with an ACE inhibitor (4;5) whilst candesartan is licensed as add-on therapy to an ACE inhibitor, a combination which … ................
................